Bromfenac disposition in patients with impaired kidney function

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 3, 1997, Pages 312-318

  Ermer, James C ^a   Boni, Joseph P ^a   Cevallos, William H ^a   DeCleene, Sheryl ^a   Burghart, Peter ^a   Rudnick, Michael R ^a   Fruncillo, Richard J ^a   Berns, Jeffrey S ^a   Cohen, Raphael M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BROMFENAC;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG LABELING; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY FUNCTION; MALE; PHARMACOKINETICS; PRIORITY JOURNAL; STEADY STATE;

ADULT; AGED; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOPHENONES; BROMOBENZENES; FEMALE; GLOMERULAR FILTRATION RATE; HALF-LIFE; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0030960496     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(97)90163-6     Document Type: Article

References (20)

1. Sancilio LF, Nolan JC, Wagner LE, Ward JW. The analgesic and anti-inflammatory activity and pharmacologic properties of bromfenac. Arzneimittelforschung 1987;37:513-9.
2. Forbes JA, Beaver WT, Jones KF, Edquist IA, Gongloff CM, Smith WK, et al. Analgesic efficacy of bromfenac, ibuprofen, and aspirin in postoperative oral surgery pain. Clin Pharmacol Ther 1992;51:343-52.
3. Forbes JA, Edquist IA, Smith FG, Schwartz MD, Beaver WT. Evaluation of bromfenac, aspirin and ibuprofen in postoperative oral surgery pain. Pharmacotherapy 1991;11:64-70.
4. Bostrom AA, Forbes JA, Adolfsson C, Beaver WT, Bell WE. Evaluation of bromfenac and ibuprofen for pain after orthopedic surgery. Pharmacotherapy 1994; 14:305-13.
5. Carroll D, Frankland T, Nagle C, McQuay H. Oral bromfenac 10 and 25 mg compared with sublingual buprenorphine 0.2 and 0.4 mg for postoperative pain relief. Br J Anaesth 1993;71:814-7.
6. McQuay HJ, Carroll D, Frankland T, Harvey M, Moore A. Bromfenac, acetaminophen and placebo in orthopedic postoperative pain. Clin Pharmacol Ther 1990;47:760-6.
7. Hogger P, Rohdewald P. Pharmacokinetics of bromfenac in healthy subjects after single oral administration of three different doses. Arzneimittelforschung 1993;43:1114-8.
8. Nolan JC, Osman MA, Cheng LK, Sancilio LF. Bromfenac, a new nonsteroidal anti-inflammatory drug: relationship between the anti-inflammatory and analgesic activity and plasma drug levels in rodents. J Pharmacol Exp Ther 1990;254:104-8.
9. Cefali EA, Poynor W J, Sica D, Cox S. Pharmacokinetic comparison of flurbiprofen in end-stage renal disease subjects and subjects with normal renal function. J Clin Pharmacol 1991;31:808-14.
10. Verbeeck RK, Blackburn JL, Loewen GR. Clinical pharmacokinetics of non-steroidal anti-inflammatory drugs. Clin Pharmacokinet 1983;8:297-331.
11. Brocks DR, Jamali F. Etodolac clinical pharmacokinetics. Clin Pharmacokinet 1994;26:259-74.
12. Chiang ST, Morrison G, Knowles JA, Ruelius HW, Walker BR. Oxaprozin disposition in renal disease. Clin Pharmacol Ther 1982;31:509-15.
13. Dieppe PA, Boyle DV, Burry HC. Renal disease in rheumatoid arthritis. Br Med J 1976;1:611-2.
14. Burry HC. Reduced glomerular function in rheumatoid arthritis. Ann Rheum Dis 1972;31:65-8.
15. Osman MA, Dunning LK, Cheng LK, Wright GJ. Determination of bromfenac in plasma by highperformance liquid chromatography. J Chromatogr 1989;489:452-8.
16. Boudinot FD, Jusko WJ. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984;73:774-80.
17. Jusko WJ. Guidelines for collection and analysis of pharmacokinetic data. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics: principles of therapeutic drug monitoring. Vancouver, WA: Applied Therapeutics, 1992:2-1-43.
18. Gibaldi M, Perrier D. Appendix D: estimation of areas. In: Pharmacokinetics; vol 15. New York: Marcel Dekker, 1982:445-9.
19. SAS/STAT user's guide. 4th ed. Cary, NC: SAS Institute, 1990.
20. Maher JF. Pharmacokinetics in patients with renal failure. Clin Nephrol 1984;21:39-46.